Literature DB >> 19230855

Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.

Ki Taek Nam1, Hyuk-Joon Lee, Hoyin Mok, Judith Romero-Gallo, James E Crowe, Richard M Peek, James R Goldenring.   

Abstract

BACKGROUND & AIMS: The loss of parietal cells from the fundic mucosa leads to the emergence of metaplastic lineages associated with an increased susceptibility to neoplastic transformation. Both intestinal metaplasia (IM) and spasmolytic polypeptide (TFF2/SP) expressing metaplasia (SPEM) have been identified in human stomach, but only SPEM is present in most mouse models of gastric metaplasia. We previously determined that loss of amphiregulin (AR) promotes SPEM induced by acute oxyntic atrophy. We have now examined whether SPEM in the AR-/- mouse predisposes the stomach to gastric neoplasia.
METHODS: Gross pathology of 18-month-old wild-type, AR-/-, and TGF-alpha-/- mice were examined. Ki-67, beta-catenin, Pdx-1, TFF3, and TFF2/SP expression was analyzed by immunohistochemistry. Metaplastic gastric mucosa was analyzed by dual immunostaining for TFF2/SP with MUC2 or TFF3.
RESULTS: By 18 months of age, more than 70% of AR-/- mice developed SPEM while 42% showed goblet cell IM labeled with MUC2, TFF3, and Pdx-1. A total of 28% had invasive gastric lesions in the fundus. No antral abnormalities were observed in AR-/- mice. Metaplastic cell lineages in AR-/- mice showed increases in cell proliferation and cytosolic beta-catenin expression. Dual staining for TFF2/SP with MUC2 or TFF3 showed glands containing both SPEM and IM with intervening cells expressing both TFF2/SP and MUC2 or TFF2/SP and TFF3.
CONCLUSIONS: AR-/- mice develop SPEM, which gives rise to goblet cell IM and invasive fundic dysplastic lesions. The AR-/- mouse represents the first mouse model for spontaneous development of fundic SPEM with progression to IM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19230855      PMCID: PMC2844775          DOI: 10.1053/j.gastro.2008.12.037

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  45 in total

1.  Processing and proliferative effects of human progastrin in transgenic mice.

Authors:  T C Wang; T J Koh; A Varro; R J Cahill; C A Dangler; J G Fox; G J Dockray
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

2.  Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies.

Authors:  Hirokazu Yamaguchi; James R Goldenring; Michio Kaminishi; Jeffrey R Lee
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 3.  Role of Helicobacter pylori gastritis in gastric atrophy, intestinal metaplasia, and gastric neoplasia.

Authors:  V C Smith; R M Genta
Journal:  Microsc Res Tech       Date:  2000-03-15       Impact factor: 2.769

4.  Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium.

Authors:  D Taupin; J Pedersen; M Familari; G Cook; N Yeomans; A S Giraud
Journal:  Lab Invest       Date:  2001-03       Impact factor: 5.662

5.  The role of transforming growth factor alpha in the enterochromaffin-like cell tumor autonomy in an African rodent mastomys.

Authors:  L H Tang; I M Modlin; G P Lawton; M Kidd; R Chinery
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

6.  Patterns of gastric atrophy in intestinal type gastric carcinoma.

Authors:  Hala M T El-Zimaity; Hiroyoshi Ota; David Y Graham; Taiji Akamatsu; Tsutomu Katsuyama
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

7.  Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice.

Authors:  Debra G Silberg; Jessica Sullivan; Eugene Kang; Gary P Swain; Jennifer Moffett; Newman J Sund; Sara D Sackett; Klaus H Kaestner
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

Review 8.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

9.  Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland.

Authors:  Anna Margrét Halldórsdóttir; Margrét Sigurdardóttrir; Jón Gunnlaugur Jónasson; Margrét Oddsdóttir; Jónas Magnússon; Jeffrey R Lee; James R Goldenring
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

10.  Restoration of E-cadherin/beta-catenin expression in pancreatic cancer cells inhibits growth by induction of apoptosis.

Authors:  Andrew M Lowy; Joy Knight; Joanna Groden
Journal:  Surgery       Date:  2002-08       Impact factor: 3.982

View more
  34 in total

1.  Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer.

Authors:  James R Goldenring; Ki Taek Nam; Timothy C Wang; Jason C Mills; Nicholas A Wright
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

Review 2.  Oxyntic atrophy, metaplasia, and gastric cancer.

Authors:  James R Goldenring; Ki Taek Nam
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.

Authors:  Victoria G Weis; Josane F Sousa; Bonnie J LaFleur; Ki Taek Nam; Jared A Weis; Paul E Finke; Nadia A Ameen; James G Fox; James R Goldenring
Journal:  Gut       Date:  2012-07-07       Impact factor: 23.059

Review 4.  Stomach development, stem cells and disease.

Authors:  Tae-Hee Kim; Ramesh A Shivdasani
Journal:  Development       Date:  2016-02-15       Impact factor: 6.868

5.  [Continual self-renewal of the gastric epithelium by cell differentiation: implications for carcinogenesis].

Authors:  W Hoffmann
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

Review 6.  Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract.

Authors:  Jason C Mills; Owen J Sansom
Journal:  Sci Signal       Date:  2015-07-14       Impact factor: 8.192

Review 7.  Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett's Stemming from SPEM.

Authors:  Ramon U Jin; Jason C Mills
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

Review 8.  Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer.

Authors:  José B Sáenz; Jason C Mills
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-02-21       Impact factor: 46.802

9.  Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium.

Authors:  Chang Mo Moon; Seok-Hyung Kim; Sang Kil Lee; Jiyeon Hyeon; Ja Seung Koo; Sangheun Lee; Jean S Wang; Won Jae Huh; Shradha S Khurana; Jason C Mills
Journal:  Dig Dis Sci       Date:  2013-12-25       Impact factor: 3.199

10.  Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori.

Authors:  Takahiro Shimizu; Eunyoung Choi; Christine P Petersen; Jennifer M Noto; Judith Romero-Gallo; Maria B Piazuelo; M Kay Washington; Richard M Peek; James R Goldenring
Journal:  J Pathol       Date:  2016-06-22       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.